An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis

BACKGROUNDS AND AIMS: There are currently no studies comparing histologic remission of FDA-approved biologics for moderate to severe ulcerative colitis (UC), except for one head-to-head VARSITY trial. The current study employs a network meta-analysis to compare the efficacy, including histologic rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Kyungsun, Seo, Yeon Sook, Yu, Yun Mi, Chang, Min Jung, Choi, Junjeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621919/
https://www.ncbi.nlm.nih.gov/pubmed/37917756
http://dx.doi.org/10.1371/journal.pone.0293655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621919/
https://www.ncbi.nlm.nih.gov/pubmed/37917756
http://dx.doi.org/10.1371/journal.pone.0293655

Ejemplares similares